BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Han G, Qi X, He C, Yin Z, Wang J, Xia J, Yang Z, Bai M, Meng X, Niu J, Wu K, Fan D. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. J Hepatol 2011;54:78-88. [PMID: 20932597 DOI: 10.1016/j.jhep.2010.06.029] [Cited by in Crossref: 164] [Cited by in F6Publishing: 174] [Article Influence: 13.7] [Reference Citation Analysis]
Number Citing Articles
1 Gao F, Wang L, Pan J, Yin Y, Wang J, Xu X, Xu S, Mancuso A, Qi X. Efficacy and safety of thrombolytic therapy for portal venous system thrombosis: A systematic review and meta-analysis. J Intern Med 2023;293:212-27. [PMID: 36208172 DOI: 10.1111/joim.13575] [Reference Citation Analysis]
2 Wu W, Zhang H, Zeng Z, Wang X, Kong D. Comparison of transjugular intrahepatic portosystemic with endoscopic treatment plus anticoagulation for esophageal variceal bleeding and portal vein thrombosis in liver cirrhosis. Scand J Gastroenterol 2022;57:1494-502. [PMID: 35802771 DOI: 10.1080/00365521.2022.2094724] [Reference Citation Analysis]
3 Tie J, Gou X, He C, Li K, Yuan X, Jia W, Niu J, Han N, Xu J, Zhu Y, Wang W. Transjugular intrahepatic collateral-systemic shunt is effective for cavernous transformation of portal vein with variceal bleeding.. [DOI: 10.21203/rs.3.rs-2282724/v1] [Reference Citation Analysis]
4 Cheng Z, Ju J, Zhu Q, Deng M, Zhang H. Intrahepatic hematoma secondary to transjugular intrahepatic portosystemic stent-shunt procedure: Case report and literature review. Medicine (Baltimore) 2022;101:e31753. [PMID: 36397433 DOI: 10.1097/MD.0000000000031753] [Reference Citation Analysis]
5 Marra P, Dulcetta L, Carbone FS, Muglia R, Muscogiuri G, Cheli M, D’antiga L, Colledan M, Fagiuoli S, Sironi S. The Role of Imaging in Portal Vein Thrombosis: From the Diagnosis to the Interventional Radiological Management. Diagnostics 2022;12:2628. [DOI: 10.3390/diagnostics12112628] [Reference Citation Analysis]
6 Odriozola A, Puente Á, Cuadrado A, Rivas C, Anton Á, González FJ, Pellón R, Fábrega E, Crespo J, Fortea JI. Portal Vein Thrombosis in the Setting of Cirrhosis: A Comprehensive Review. JCM 2022;11:6435. [DOI: 10.3390/jcm11216435] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Chen Y, Ma X, Zhang X, Luo J, An L, Zhang Y, Chang X, Dong Z, Zhang W, Kong H, Zhao J, Ding H, Liu F, Yang Y. Prevention of variceal rebleeding in cirrhotic patients with advanced hepatocellular carcinoma receiving molecularly targeted therapy: a randomized pilot study of transjugular intrahepatic portosystemic shunt versus endoscopic plus β-blocker. Hepatol Int 2022. [PMID: 36255564 DOI: 10.1007/s12072-022-10388-7] [Reference Citation Analysis]
8 Zurcher KS, Smith MV, Naidu SG, Saini G, Patel IJ, Knuttinen MG, Kriegshauser JS, Oklu R, Alzubaidi SJ. Transsplenic Portal System Catheterization: Review of Current Indications and Techniques. Radiographics 2022;:220042. [PMID: 35984753 DOI: 10.1148/rg.220042] [Reference Citation Analysis]
9 Guo D, Fan L, Le Q, Huang C. Transjugular intrahepatic portosystemic shunt for the prevention of rebleeding in patients with cirrhosis and portal vein thrombosis: Systematic review and meta-analysis. Front Pharmacol 2022;13:968988. [DOI: 10.3389/fphar.2022.968988] [Reference Citation Analysis]
10 Ghosh A, Seyoum N, Anand S, Akhter N. Percutaneous CT-guided superior mesenteric vein access for portal vein recanalization-transjugular intrahepatic portosystemic shunt. Radiology Case Reports 2022;17:2603-6. [DOI: 10.1016/j.radcr.2022.04.025] [Reference Citation Analysis]
11 Qiu Z, Wang G, Yan H, Qi H, Zuo M, Wang G, Jiang W, Chen Z, Xue J, Lu L, Zhang F, Gao F. TIPS plus sequential systemic therapy of advanced HCC patients with tumour thrombus-related symptomatic portal hypertension. Eur Radiol 2022. [PMID: 35441840 DOI: 10.1007/s00330-022-08705-7] [Reference Citation Analysis]
12 Mansour N, Öcal O, Gerwing M, Köhler M, Deniz S, Heinzow H, Steib C, Angele MK, Seidensticker M, Ricke J, Wildgruber M. Interventional recanalization therapy in patients with non-cirrhotic, non-malignant portal vein thrombosis: comparison between transjugular versus transhepatic access. Abdom Radiol (NY) 2022;47:1177-86. [PMID: 35020007 DOI: 10.1007/s00261-022-03411-w] [Reference Citation Analysis]
13 Wang P, Qi X, Xu K. Evolution, progress, and prospects of research on transjugular intrahepatic portosystemic shunt applications. J Interv Med 2021;4:57-61. [PMID: 34805949 DOI: 10.1016/j.jimed.2021.02.001] [Reference Citation Analysis]
14 Knight GM, Clark J, Boike JR, Maddur H, Ganger DR, Talwar A, Riaz A, Desai K, Mouli S, Hohlastos E, Garcia Pagan JC, Gabr A, Stein B, Lewandowski R, Thornburg B, Salem R. TIPS for Adults Without Cirrhosis With Chronic Mesenteric Venous Thrombosis and EHPVO Refractory to Standard-of-Care Therapy. Hepatology 2021;74:2735-44. [PMID: 34021505 DOI: 10.1002/hep.31915] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
15 Lv Y, Han G. Response to Jindal and Mukund. Am J Gastroenterol 2021;116:2306. [PMID: 34543255 DOI: 10.14309/ajg.0000000000001496] [Reference Citation Analysis]
16 Wang HL, Lu WJ, Zhang YL, Nie CH, Zhou TY, Zhou GH, Zhu TY, Wang BQ, Chen SQ, Yu ZN, Jing L, Sun JH. Comparison of Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Cirrhosis With or Without Portal Vein Thrombosis: A Retrospective Study. Front Med (Lausanne) 2021;8:737984. [PMID: 34671621 DOI: 10.3389/fmed.2021.737984] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Molvar C, Amin P. Portal Vein Thrombosis In Cirrhosis: Interventional Treatment Options. Curr Gastroenterol Rep 2021;23:24. [PMID: 34654971 DOI: 10.1007/s11894-021-00826-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Yeoh SW, Kok HK. Transjugular intrahepatic portosystemic shunts in portal vein thrombosis: A review. J Dig Dis 2021;22:506-19. [PMID: 34323378 DOI: 10.1111/1751-2980.13035] [Reference Citation Analysis]
19 Senzolo M, Garcia-Tsao G, García-Pagán JC. Current knowledge and management of portal vein thrombosis in cirrhosis. J Hepatol 2021;75:442-53. [PMID: 33930474 DOI: 10.1016/j.jhep.2021.04.029] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 15.5] [Reference Citation Analysis]
20 Zhang JB, Chen J, Zhou J, Wang XM, Chen S, Chu JG, Liu P, Ye ZD. Systematic review and meta-analysis of trans-jugular intrahepatic portosystemic shunt for cirrhotic patients with portal vein thrombosis. World J Clin Cases 2021; 9(19): 5179-5190 [PMID: 34307565 DOI: 10.12998/wjcc.v9.i19.5179] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
21 Lv Y, Bai W, Li K, Wang Z, Guo W, Luo B, Wang J, Wang Q, Wang E, Xia D, Li X, Yuan J, Han N, Niu J, Yin Z, Fan D, Han G. Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study. Am J Gastroenterol 2021;116:1447-64. [PMID: 33630766 DOI: 10.14309/ajg.0000000000001194] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
22 Sen I, Yohanathan L, Kärkkäinen JM, Nagorney DM. Current Indications and Long-Term Outcomes of Surgical Portosystemic Shunts in Adults. J Gastrointest Surg 2021;25:1437-44. [PMID: 32424687 DOI: 10.1007/s11605-020-04643-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
23 Sun XY, Wang GC, Wang J, Huang GJ, Zhang CQ. Transjugular intrahepatic portosystemic shunt is effective in patients with chronic portal vein thrombosis and variceal bleeding. Hepatobiliary Pancreat Dis Int 2021;20:128-36. [PMID: 33455864 DOI: 10.1016/j.hbpd.2020.12.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Hepatobiliary Disease Study Group, Chinese Society of Gastroenterology, Chinese Medical Association. Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai). J Dig Dis 2021;22:176-86. [PMID: 33470535 DOI: 10.1111/1751-2980.12970] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
25 Wu WY, Kong DR. Advances in diagnosis and treatment of portal venous thrombosis. Shijie Huaren Xiaohua Zazhi 2021; 29(4): 165-173 [DOI: 10.11569/wcjd.v29.i4.165] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Stotts MJ, Wentworth BJ, Northup PG. Management of Portal Vein Thrombosis in Cirrhosis. Semin Liver Dis 2021;41:79-86. [PMID: 33764487 DOI: 10.1055/s-0040-1722260] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
27 Elhence A, Gamanagatti SR, Shalimar. Transjugular Intrahepatic Portosystemic Shunt for Non-malignant Portal Vein Thrombosis. Portal Vein Thrombosis 2021. [DOI: 10.1007/978-981-33-6538-4_9] [Reference Citation Analysis]
28 Durand F, Dokmak S, Roux O, Francoz C. Liver Transplantation in the Setting of Non-malignant Portal Vein Thrombosis. Portal Vein Thrombosis 2021. [DOI: 10.1007/978-981-33-6538-4_10] [Reference Citation Analysis]
29 Taunk A, Mukund A. IR Management of Nonmalignant Portal Vein Thrombosis. Basics of Hepatobiliary Interventions 2021. [DOI: 10.1007/978-981-15-6856-5_9] [Reference Citation Analysis]
30 Rugivarodom M, Charatcharoenwitthaya P. Nontumoral Portal Vein Thrombosis: A Challenging Consequence of Liver Cirrhosis. J Clin Transl Hepatol 2020;8:432-44. [PMID: 33447527 DOI: 10.14218/JCTH.2020.00067] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
31 Barbier CE, Rorsman F, Eriksson LG, Sangfelt P, Sheikhi R, Vessby J, Nyman R. Placement of a transjugular intrahepatic portosystemic shunt in addition to recanalization of acute and chronic portomesenteric vein occlusions - a retrospective evaluation. Acta Radiol Open 2020;9:2058460120964074. [PMID: 33110628 DOI: 10.1177/2058460120964074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
32 Li M, Luo J, Chen J, Wu C, Pan T, Huang M, Jiang Z. Application of percutaneous transluminal sharp recanalization in transjugular intrahepatic portosystemic shunt for patients with chronic portal vein occlusion. Diagn Interv Radiol 2021;27:257-62. [PMID: 33044172 DOI: 10.5152/dir.2020.20461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 Yan H, Wang G, Zhu W, Feng K, Zhu W, Wu X, Qiu Z, Chen G, Jiang W, Zhang F, Gao F. Feasibility and clinical value of TIPS combined with subsequent antitumor treatment in HCC patients with refractory ascites. Transl Oncol 2020;13:100864. [PMID: 32950928 DOI: 10.1016/j.tranon.2020.100864] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Nicoară-Farcău O, Soy G, Magaz M, Baiges A, Turon F, Garcia-Criado A, Barrufet M, Burrel M, Hernández-Gea V, García-Pagán JC. New Insights into the Pathogenesis, Risk Factors, and Treatment of Portal Vein Thrombosis in Patients with Cirrhosis. Semin Thromb Hemost 2020;46:673-81. [PMID: 32820481 DOI: 10.1055/s-0040-1715473] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
35 Boike JR, Flamm SL. Transjugular Intrahepatic Portosystemic Shunts: Advances and New Uses in Patients with Chronic Liver Disease. Clin Liver Dis 2020;24:373-88. [PMID: 32620278 DOI: 10.1016/j.cld.2020.04.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Modaresi Esfeh J, Ansari-Gilani K. Transjugular intrahepatic portosystemic shunt in cirrhotic patients with portal vein thrombosis. Eur J Gastroenterol Hepatol 2020;32:762-3. [PMID: 32355095 DOI: 10.1097/MEG.0000000000001680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
37 Chen H, He C, Lv Y, Fan J, Tang S, Niu J, Yuan J, Luo B, Guo W, Yin Z, Han G. Long-term results of variceal bleeding management in 302 patients with chronic extrahepatic portal vein obstruction. J Gastroenterol Hepatol 2020;35:1049-56. [PMID: 31677186 DOI: 10.1111/jgh.14902] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
38 Bhangui P, Fernandes ESM, Di Benedetto F, Joo DJ, Nadalin S. Current management of portal vein thrombosis in liver transplantation. Int J Surg 2020;82S:122-7. [PMID: 32387201 DOI: 10.1016/j.ijsu.2020.04.068] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
39 Zhang R, Lu S, Jiang YY, Ma JQ, Zhang W, Gu JY, Wang J, Chen SY. A Preclinical Porcine Model of Portal Vein Thrombosis in Liver Cirrhosis. Biomed Res Int 2020;2020:3086906. [PMID: 32351989 DOI: 10.1155/2020/3086906] [Reference Citation Analysis]
40 Niu XK, Das SK, Wu HL, Chen Y. Computed tomography-based score model/nomogram for predicting technical and midterm outcomes in transjugular intrahepatic portosystemic shunt treatment for symptomatic portal cavernoma. World J Clin Cases 2020; 8(5): 887-899 [PMID: 32190625 DOI: 10.12998/wjcc.v8.i5.887] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
41 Miraglia R, Maruzzelli L, Cannataci C, Gerasia R, Mamone G, Cortis K, Cimò B, Petridis I, Volpes R, Luca A. Radiation exposure during transjugular intrahepatic portosystemic shunt creation in patients with complete portal vein thrombosis or portal cavernoma. Radiol med 2020;125:609-17. [DOI: 10.1007/s11547-020-01155-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
42 Zhang L, Huan H, Tong H, Wei B, Wang Z, Liu C, Wu H. Warfarin prevented de novo portal vein thrombosis after transjugular intrahepatic portosystemic shunt: A retrospective study. Medicine (Baltimore) 2020;99:e18737. [PMID: 31914090 DOI: 10.1097/MD.0000000000018737] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
43 Dong F, Luo SH, Zheng LJ, Chu JG, Huang H, Zhang XQ, Yao KC. Incidence of portal vein thrombosis after splenectomy and its influence on transjugular intrahepatic portosystemic shunt stent patency. World J Clin Cases 2019; 7(17): 2450-2462 [PMID: 31559281 DOI: 10.12998/wjcc.v7.i17.2450] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
44 Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis. Gastroenterology 2019;156:1582-1599.e1. [PMID: 30771355 DOI: 10.1053/j.gastro.2019.01.265] [Cited by in Crossref: 140] [Cited by in F6Publishing: 142] [Article Influence: 35.0] [Reference Citation Analysis]
45 Zhang Y, Wu YF, Yue ZD, Zhao HW, Wang L, Fan ZH, He FL, Wang T, Liu FQ. Iodine-125 implantation with transjugular intrahepatic portosystemic shunt for main portal vein tumor thrombus. World J Gastrointest Oncol 2019; 11(4): 310-321 [PMID: 31040896 DOI: 10.4251/wjgo.v11.i4.310] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
46 Lv Y, Li K, He C, Luo B, Zhang B, Liu H, Wang Z, Guo W, Wang Q, Chen H, Bai W, Yuan X, Yu T, Li X, Yuan J, Han N, Zhu Y, Niu J, Xie H, Wang J, Chen L, Yin Z, Fan D, Li Z, Han G. TIPSS for variceal bleeding in patients with idiopathic non-cirrhotic portal hypertension: comparison with patients who have cirrhosis. Aliment Pharmacol Ther 2019;49:926-39. [PMID: 30820990 DOI: 10.1111/apt.15186] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
47 Elkrief L, Valla D. Hepatic Venous Outflow Syndromes and Splanchnic Venous Thrombosis. Evidence-based Gastroenterology and Hepatology 4e 2019. [DOI: 10.1002/9781119211419.ch42] [Reference Citation Analysis]
48 Zuo L, Lv Y, Wang Q, Yin Z, Wang Z, He C, Guo W, Niu J, Bai W, Li K, Yu T, Yuan X, Chen H, Liu H, Xia D, Wang E, Luo B, Li X, Yuan J, Han N, Nie Y, Fan D, Han G. Early-Recurrent Overt Hepatic Encephalopathy Is Associated with Reduced Survival in Cirrhotic Patients after Transjugular Intrahepatic Portosystemic Shunt Creation. J Vasc Interv Radiol. 2019;30:148-153.e2. [PMID: 30638778 DOI: 10.1016/j.jvir.2018.08.023] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
49 Rodrigues SG, Sixt S, Abraldes JG, De Gottardi A, Klinger C, Bosch J, Baumgartner I, Berzigotti A. Systematic review with meta-analysis: portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis. Aliment Pharmacol Ther 2019;49:20-30. [PMID: 30450634 DOI: 10.1111/apt.15044] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 11.5] [Reference Citation Analysis]
50 Kuetting D, Wolter K, Luetkens J, Trebicka J, Praktiknjo M, Thomas D, Meyer C. AngioJet-assisted transvenous-transhepatic mechanical thrombectomy in the portal vein. Pol J Radiol 2018;83:e536-44. [PMID: 30805065 DOI: 10.5114/pjr.2018.81380] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
51 Li ZP, Wang SS, Wang GC, Huang GJ, Cao JQ, Zhang CQ. Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein. Hepatobiliary Pancreat Dis Int 2018;17:517-23. [PMID: 30262421 DOI: 10.1016/j.hbpd.2018.09.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
52 Lv Y, Qi X, He C, Wang Z, Yin Z, Niu J, Guo W, Bai W, Zhang H, Xie H, Yao L, Wang J, Li T, Wang Q, Chen H, Liu H, Wang E, Xia D, Luo B, Li X, Yuan J, Han N, Zhu Y, Xia J, Cai H, Yang Z, Wu K, Fan D, Han G; PVT-TIPS Study Group. Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial. Gut 2018;67:2156-68. [PMID: 28970291 DOI: 10.1136/gutjnl-2017-314634] [Cited by in Crossref: 88] [Cited by in F6Publishing: 88] [Article Influence: 17.6] [Reference Citation Analysis]
53 Valentin N, Korrapati P, Constantino J, Young A, Weisberg I. The role of transjugular intrahepatic portosystemic shunt in the management of portal vein thrombosis: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2018;30:1187-93. [PMID: 30074506 DOI: 10.1097/MEG.0000000000001219] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 6.6] [Reference Citation Analysis]
54 Wang Q, Han G. Image-guided treatment of Budd-Chiari syndrome: a giant leap from the past, a small step towards the future. Abdom Radiol (NY) 2018;43:1908-19. [PMID: 28988356 DOI: 10.1007/s00261-017-1341-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
55 Aggeletopoulou I, Konstantakis C, Manolakopoulos S, Triantos C. Role of band ligation for secondary prophylaxis of variceal bleeding. World J Gastroenterol 2018;24:2902-14. [PMID: 30018485 DOI: 10.3748/wjg.v24.i26.2902] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
56 Wan YM, Li YH, Xu Y, Wu HM, Li YC, Wu XN, Yang JH. Predictors of Shunt Dysfunction and Overall Survival in Patients with Variceal Bleeding Treated with Transjugular Portosystemic Shunt Creation Using the Fluency Stent Graft. Acad Radiol 2018;25:925-34. [PMID: 29373208 DOI: 10.1016/j.acra.2017.11.020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
57 Merola J, Fortune BE, Deng Y, Ciarleglio M, Amirbekian S, Chaudhary N, Shanbhogue A, Ayyagari R, Rodriguez-Davalos MI, Teperman L, Charles HW, Sigal SH. Transjugular intrahepatic portosystemic shunt creation for cirrhotic portal hypertension is well tolerated among patients with portal vein thrombosis. Eur J Gastroenterol Hepatol 2018;30:668-75. [PMID: 29462027 DOI: 10.1097/MEG.0000000000001097] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
58 Rössle M MD, Schultheiss M. Timing of the Treatment of Portal Vein Thrombosis in Patients with Cirrhosis: A German Hepatologist's Perspective. J Transl Int Med 2018;6:11-5. [PMID: 29607298 DOI: 10.2478/jtim-2018-0003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
59 Mantaka A, Augoustaki A, Kouroumalis EA, Samonakis DN. Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges. Ann Gastroenterol 2018;31:315-29. [PMID: 29720857 DOI: 10.20524/aog.2018.0245] [Cited by in Crossref: 9] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
60 Lombardo S, Espejo J, Pérez-montilla M, Zurera L, González-galilea Á. The keys to successful TIPS in patients with portal vein thrombosis and cavernous transformation. Radiología (English Edition) 2018;60:94-104. [DOI: 10.1016/j.rxeng.2018.02.001] [Reference Citation Analysis]
61 Tavare AN, Wigham A, Hadjivassilou A, Alvi A, Papadopoulou A, Goode A, Woodward N, Patch D, Yu D, Davies N. Use of transabdominal ultrasound-guided transjugular portal vein puncture on radiation dose in transjugular intrahepatic portosystemic shunt formation. Diagn Interv Radiol. 2017;23:206-210. [PMID: 28223261 DOI: 10.5152/dir.2016.15601] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
62 Elkrief L, Valla DC. Portal and Splenic Vein Thrombosis. Zakim and Boyer's Hepatology 2018. [DOI: 10.1016/b978-0-323-37591-7.00045-8] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
63 Maiwall R, Sarin SK. Extrahepatic Portal Vein Obstruction: Asian and Global Perspective. Diagnostic Methods for Cirrhosis and Portal Hypertension 2018. [DOI: 10.1007/978-3-319-72628-1_18] [Reference Citation Analysis]
64 Saeian K, Kohli A, Ahn J. Portal Hypertensive Gastrointestinal Bleeding. Hepatic Critical Care 2018. [DOI: 10.1007/978-3-319-66432-3_10] [Reference Citation Analysis]
65 Jiang TT, Luo XP, Sun JM, Gao J. Clinical outcomes of transcatheter selective superior mesenteric artery urokinase infusion therapy vs transjugular intrahepatic portosystemic shunt in patients with cirrhosis and acute portal vein thrombosis. World J Gastroenterol 2017; 23(41): 7470-7477 [PMID: 29151701 DOI: 10.3748/wjg.v23.i41.7470] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
66 Lombardo S, Espejo JJ, Pérez-Montilla ME, Zurera LJ, González-Galilea Á. The keys to successful TIPS in patients with portal vein thrombosis and cavernous transformation. Radiologia (Engl Ed) 2018;60:94-104. [PMID: 29122309 DOI: 10.1016/j.rx.2017.08.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
67 Torres-Machorro A, Guerrero-Hernandez M, Anaya-Ayala JE, Torre A, Laparra-Escareno H, Cuen-Ojeda C, Garcia-Alva R, Hinojosa CA. Analysis of the MELD Score Impact in the Outcome of Endovascular Portal Vein Reconstruction. Ann Hepatol 2017;16:950-8. [PMID: 29055930 DOI: 10.5604/01.3001.0010.5287] [Reference Citation Analysis]
68 Martín-llahí M, Albillos A, Bañares R, Berzigotti A, García-criado MÁ, Genescà J, Hernández-gea V, Llop-herrera E, Masnou-ridaura H, Mateo J, Navascués CA, Puente Á, Romero-gutiérrez M, Simón-talero M, Téllez L, Turon F, Villanueva C, Zarrabeitia R, García-pagán JC. Enfermedades vasculares del hígado. Guías Clínicas de la Sociedad Catalana de Digestología y de la Asociación Española para el Estudio del Hígado. Gastroenterología y Hepatología 2017;40:538-80. [DOI: 10.1016/j.gastrohep.2017.03.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
69 Martín-llahí M, Albillos A, Bañares R, Berzigotti A, García-criado MÁ, Genescà J, Hernández-gea V, Llop-herrera E, Masnou-ridaura H, Mateo J, Navascués CA, Puente Á, Romero-gutiérrez M, Simón-talero M, Téllez L, Turon F, Villanueva C, Zarrabeitia R, García-pagán JC. Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver. Gastroenterología y Hepatología (English Edition) 2017;40:538-580. [DOI: 10.1016/j.gastre.2017.03.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
70 Wang L, He F, Yue Z, Zhao H, Fan Z, Zhao M, Qiu B, Yao J, Lin Q, Dong X, Liu F. Techniques and long-term effects of transjugular intrahepatic portosystemic shunt on liver cirrhosis-related thrombotic total occlusion of main portal vein. Sci Rep. 2017;7:10868. [PMID: 28883536 DOI: 10.1038/s41598-017-11455-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
71 Wang Q, Lv Y, Bai M, Wang Z, Liu H, He C, Niu J, Guo W, Luo B, Yin Z, Bai W, Chen H, Wang E, Xia D, Li X, Yuan J, Han N, Cai H, Li T, Xie H, Xia J, Wang J, Zhang H, Wu K, Fan D, Han G. Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding. J Hepatol 2017;67:508-16. [PMID: 28506905 DOI: 10.1016/j.jhep.2017.05.006] [Cited by in Crossref: 86] [Cited by in F6Publishing: 86] [Article Influence: 14.3] [Reference Citation Analysis]
72 Wang Q, Lv Y, Chen H, Shao J, Han G. Use of 8-mm Covered TIPS: Is "Losses without Gains" the End of the Story? Radiology 2017;284:604. [PMID: 28723295 DOI: 10.1148/radiol.2017170468] [Reference Citation Analysis]
73 Dhaliwal A, Armstrong MJ, Tripathi D. Patient Selection for Transjugular Intrahepatic Portosystemic Stent Shunt (TIPSS) Insertion in Variceal Bleeding and Refractory Ascites. Curr Hepatology Rep 2017;16:241-9. [DOI: 10.1007/s11901-017-0361-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
74 Lv Y, He C, Wang Z, Guo W, Wang J, Bai W, Zhang L, Wang Q, Liu H, Luo B. Association of Nonmalignant Portal Vein Thrombosis and Outcomes after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis. Radiology. 2017;285:999-1010. [PMID: 28682164 DOI: 10.1148/radiol.2017162266] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
75 Trifan A, Stanciu C, Girleanu I. Portal Vein Thrombosis in Patients with Liver Cirrhosis. Liver Cirrhosis - Update and Current Challenges 2017. [DOI: 10.5772/intechopen.68929] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
76 Haris M, Thachil J. Portal vein thrombosis - a primer for the general physician. Clin Med (Lond) 2017;17:212-9. [PMID: 28572222 DOI: 10.7861/clinmedicine.17-3-212] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
77 Qiu B, Li K, Dong X, Liu FQ. Transjugular Intrahepatic Portosystemic Shunt for Portal Hypertension in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Cardiovasc Intervent Radiol. 2017;40:1372-1382. [PMID: 28488102 DOI: 10.1007/s00270-017-1655-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
78 von Köckritz L, De Gottardi A, Trebicka J, Praktiknjo M. Portal vein thrombosis in patients with cirrhosis. Gastroenterol Rep (Oxf) 2017;5:148-56. [PMID: 28533912 DOI: 10.1093/gastro/gox014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
79 Mancuso A. Portal Vein Thrombosis and Cirrhosis: The Role of Anticoagulation. Curr Hepatology Rep 2017;16:158-63. [DOI: 10.1007/s11901-017-0344-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
80 Wang CM, Li X, Fu J, Luan JY, Li TR, Zhao J, Dong GX. Construction of Transjugular Intrahepatic Portosystemic Shunt: Bare Metal Stent/Stent-graft Combination versus Single Stent-graft, a Prospective Randomized Controlled Study with Long-term Patency and Clinical Analysis. Chin Med J (Engl) 2016;129:1261-7. [PMID: 27231160 DOI: 10.4103/0366-6999.182830] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
81 Fagiuoli S, Bruno R, Debernardi Venon W, Schepis F, Vizzutti F, Toniutto P, Senzolo M, Caraceni P, Salerno F, Angeli P, Cioni R, Vitale A, Grosso M, De Gasperi A, D'Amico G, Marzano A; AISF TIPS Special Conference. Consensus conference on TIPS management: Techniques, indications, contraindications. Dig Liver Dis 2017;49:121-37. [PMID: 27884494 DOI: 10.1016/j.dld.2016.10.011] [Cited by in Crossref: 77] [Cited by in F6Publishing: 68] [Article Influence: 12.8] [Reference Citation Analysis]
82 Trebicka J. Emergency TIPS in a Child-Pugh B patient: When does the window of opportunity open and close? J Hepatol 2017;66:442-50. [PMID: 27984174 DOI: 10.1016/j.jhep.2016.10.025] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 9.8] [Reference Citation Analysis]
83 Yue-Meng W, Li YH, Wu HM, Yang J, Yang LH, Xu Y. Portal Vein Thrombosis in Patients With Cirrhosis Undergoing Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors, Warfarin Efficacy, and Clinical Outcomes. Clin Appl Thromb Hemost 2018;24:462-70. [PMID: 28110540 DOI: 10.1177/1076029616689593] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
84 Darcy MD. Transjugular intrahepatic portosystemic shunting. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set 2017. [DOI: 10.1016/b978-0-323-34062-5.00087-x] [Reference Citation Analysis]
85 Qi X, Guo X. An early decision of transjugular intrahepatic portosystemic shunt may be considered for non-malignant and non-cirrhotic portal vein thrombosis with ascites: a concise review of the theoretical possibility and practical difficulty. Arch Med Sci 2016;12:1381-3. [PMID: 27904533 DOI: 10.5114/aoms.2016.62921] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
86 Zhao M, Yue Z, Zhao H, Wang L, Fan Z, He F, Yao J, Dong X, Liu F. Techniques of TIPS in the treatment of liver cirrhosis combined with incompletely occlusive main portal vein thrombosis. Sci Rep. 2016;6:33069. [PMID: 27620282 DOI: 10.1038/srep33069] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
87 Dell’era A, Seijo S. Portal vein thrombosis in cirrhotic and non cirrhotic patients: from diagnosis to treatment. Expert Opinion on Orphan Drugs 2016;4:927-40. [DOI: 10.1080/21678707.2016.1215907] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
88 Jiang Q, Wang MQ, Zhang GB, Wu Q, Xu JM, Kong DR. Transjugular intrahepatic portosystemic shunt combined with esophagogastric variceal embolization in the treatment of a large gastrorenal shunt. World J Hepatol 2016; 8(20): 850-857 [PMID: 27458505 DOI: 10.4254/wjh.v8.i20.850] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
89 Mancuso A. Management of portal vein thrombosis in cirrhosis: an update. Eur J Gastroenterol Hepatol 2016;28:739-43. [PMID: 27075588 DOI: 10.1097/MEG.0000000000000633] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
90 Bissonnette J, Garcia-Pagán JC, Albillos A, Turon F, Ferreira C, Tellez L, Nault JC, Carbonell N, Cervoni JP, Abdel Rehim M, Sibert A, Bouchard L, Perreault P, Trebicka J, Trottier-Tellier F, Rautou PE, Valla DC, Plessier A. Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertension. Hepatology 2016;64:224-31. [PMID: 26990687 DOI: 10.1002/hep.28547] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 6.6] [Reference Citation Analysis]
91 Pargewar SS, Desai SN, Rajesh S, Singh VP, Arora A, Mukund A. Imaging and radiological interventions in extra-hepatic portal vein obstruction. World J Radiol 2016; 8(6): 556-570 [PMID: 27358683 DOI: 10.4329/wjr.v8.i6.556] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
92 Salsamendi JT, Gortes FJ, Shnayder M, Doshi MH, Fan J, Narayanan G. Transsplenic portal vein reconstruction-transjugular intrahepatic portosystemic shunt in a patient with portal and splenic vein thrombosis. Radiol Case Rep 2016;11:186-9. [PMID: 27594947 DOI: 10.1016/j.radcr.2016.05.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
93 Madoff DC, Gaba RC, Weber CN, Clark TW, Saad WE. Portal Venous Interventions: State of the Art. Radiology. 2016;278:333-353. [PMID: 26789601 DOI: 10.1148/radiol.2015141858] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 5.6] [Reference Citation Analysis]
94 Qi X, He C, Guo W, Yin Z, Wang J, Wang Z, Niu J, Bai M, Yang Z, Fan D, Han G. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study. Liver Int 2016;36:667-76. [PMID: 26235541 DOI: 10.1111/liv.12929] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 6.0] [Reference Citation Analysis]
95 Rosenqvist K, Eriksson LG, Rorsman F, Sangfelt P, Nyman R. Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver. Acta Radiol 2016;57:572-9. [PMID: 26253926 DOI: 10.1177/0284185115595060] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 5.1] [Reference Citation Analysis]
96 Yu H, Guo S, Wang L, Dong Y, Tian G, Mu S, Zhang H, Li D, Zhao S. Laparoscopic Splenectomy and Esophagogastric Devascularization for Liver Cirrhosis and Portal Hypertension Is a Safe, Effective, and Minimally Invasive Operation. J Laparoendosc Adv Surg Tech A. 2016;26:524-530. [PMID: 27064936 DOI: 10.1089/lap.2016.0032] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
97 Chen H, Turon F, Hernández-Gea V, Fuster J, Garcia-Criado A, Barrufet M, Darnell A, Fondevila C, Garcia-Valdecasas JC, Garcia-Pagán JC. Nontumoral portal vein thrombosis in patients awaiting liver transplantation. Liver Transpl 2016;22:352-65. [PMID: 26684272 DOI: 10.1002/lt.24387] [Cited by in Crossref: 77] [Cited by in F6Publishing: 72] [Article Influence: 11.0] [Reference Citation Analysis]
98 Wang Z, Zhao H, Wang X, Zhang H, Jiang M, Tsauo J, Luo X, Yang L, Li X. Clinical outcome comparison between TIPS and EBL in patients with cirrhosis and portal vein thrombosis. Abdom Imaging. 2015;40:1813-1820. [PMID: 25504374 DOI: 10.1007/s00261-014-0320-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
99 Wang L, Xiao Z, Yue Z, Zhao H, Fan Z, Zhao M, He F, Dai S, Qiu B, Yao J, Lin Q, Dong X, Liu F. Efficacy of covered and bare stent in TIPS for cirrhotic portal hypertension: A single-center randomized trial. Sci Rep. 2016;6:21011. [PMID: 26876503 DOI: 10.1038/srep21011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
100 Salem R, Vouche M, Baker T, Herrero JI, Caicedo JC, Fryer J, Hickey R, Habib A, Abecassis M, Koller F, Vogelzang R, Desai K, Thornburg B, Hohlastos E, Resnick S, Lewandowski RJ, Sato K, Ryu RK, Ganger D, Kulik L. Pretransplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Complete Obliterative Portal Vein Thrombosis. Transplantation. 2015;99:2347-2355. [PMID: 25905983 DOI: 10.1097/tp.0000000000000729] [Cited by in Crossref: 91] [Cited by in F6Publishing: 97] [Article Influence: 13.0] [Reference Citation Analysis]
101 Lv Y, He C, Guo W, Yin Z, Wang J, Zhang B, Meng X, Cai J, Luo B, Wu F, Niu J, Fan D, Han G. Transjugular Intrahepatic Portosystemic Shunt for Extrahepatic Portal Venous Obstruction in Children. J Pediatr Gastroenterol Nutr 2016;62:233-41. [PMID: 26381818 DOI: 10.1097/MPG.0000000000000982] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
102 European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. EASL Clinical Practice Guidelines: Vascular diseases of the liver. J Hepatol 2016;64:179-202. [PMID: 26516032 DOI: 10.1016/j.jhep.2015.07.040] [Cited by in Crossref: 405] [Cited by in F6Publishing: 403] [Article Influence: 57.9] [Reference Citation Analysis]
103 Zhang M, Valentino MA. Bilhemia: A Rare Complication of Transjugular Intraheptic Portosytemic Shunt. ACG Case Reports Journal 2016;3:60-62. [DOI: 10.14309/crj.2015.101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
104 Jeong SY, Park AW, Wilkins L. Transjugular intrahepatic portosystemic shunt using transsplenic access with balloon-assisted puncture technique in a patient with chronic and complete occlusion of portal vein. Gastrointestinal Intervention 2015;4:127-9. [DOI: 10.18528/gii150028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
105 Wang Z, Jiang MS, Zhang HL, Weng NN, Luo XF, Li X, Yang L. Is Post-TIPS Anticoagulation Therapy Necessary in Patients with Cirrhosis and Portal Vein Thrombosis? Radiology. 2016;279:943-951. [PMID: 26653681 DOI: 10.1148/radiol.2015150369] [Cited by in Crossref: 69] [Cited by in F6Publishing: 69] [Article Influence: 8.6] [Reference Citation Analysis]
106 Pardo F, Pons JA, Briceño J. V Consensus Meeting of the Spanish Society for Liver Transplant on High-Risk Recipients, Immunosupression Scenarios and Management of Hepatocarcinoma on the Transplant Waiting List. Cirugía Española (English Edition) 2015;93:619-637. [DOI: 10.1016/j.cireng.2015.04.010] [Reference Citation Analysis]
107 Pardo F, Pons JA, Briceño J. V Reunión de Consenso de la Sociedad Española de Trasplante Hepático sobre receptores de riesgo elevado, escenarios actuales de inmunosupresión y manejo del hepatocarcinoma en espera de trasplante. Cirugía Española 2015;93:619-37. [DOI: 10.1016/j.ciresp.2015.04.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
108 Pardo F, Pons JA, Briceño J. V Reunión de Consenso de la Sociedad Española de Trasplante Hepático sobre receptores de riesgo elevado, escenarios actuales de inmunosupresión y manejo del hepatocarcinoma en espera de trasplante. Gastroenterología y Hepatología 2015;38:600-18. [DOI: 10.1016/j.gastrohep.2015.06.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
109 Dariushnia SR, Haskal ZJ, Midia M, Martin LG, Walker TG, Kalva SP, Clark TW, Ganguli S, Krishnamurthy V, Saiter CK, Nikolic B; Society of Interventional Radiology Standards of Practice Committee. Quality Improvement Guidelines for Transjugular Intrahepatic Portosystemic Shunts. J Vasc Interv Radiol. 2016;27:1-7. [PMID: 26614596 DOI: 10.1016/j.jvir.2015.09.018] [Cited by in Crossref: 84] [Cited by in F6Publishing: 91] [Article Influence: 10.5] [Reference Citation Analysis]
110 Sabol TP, Molina M, Wu GY. Thrombotic Venous Diseases of the Liver. J Clin Transl Hepatol 2015;3:189-94. [PMID: 26623265 DOI: 10.14218/JCTH.2015.00014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
111 Huard G, Bissonnette J, Bilodeau M. Optimal Management of Portal Vein Thrombosis in Patients with Liver Cirrhosis: a Review. Curr Hepatology Rep 2015;14:203-211. [DOI: 10.1007/s11901-015-0273-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
112 Lv Y, Qi X, Xia J, Fan D, Han G. Integrity of Data in a Randomized Controlled Trial. Radiology 2015;276:930-1. [PMID: 26302396 DOI: 10.1148/radiol.2015150713] [Reference Citation Analysis]
113 Rössle M, Bausch B, Klinger C. Therapy Algorithm for Portal Vein Thrombosis in Liver Cirrhosis: The Internist's Point of View. Viszeralmedizin 2014;30:401-8. [PMID: 26288607 DOI: 10.1159/000370053] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
114 Harding DJ, Perera MTP, Chen F, Olliff S, Tripathi D. Portal vein thrombosis in cirrhosis: Controversies and latest developments. World J Gastroenterol 2015; 21(22): 6769-6784 [PMID: 26078553 DOI: 10.3748/wjg.v21.i22.6769] [Cited by in CrossRef: 64] [Cited by in F6Publishing: 73] [Article Influence: 8.0] [Reference Citation Analysis]
115 Qi X, Su C, Ren W, Yang M, Jia J, Dai J, Xu W, Guo X. Association between portal vein thrombosis and risk of bleeding in liver cirrhosis: A systematic review of the literature. Clin Res Hepatol Gastroenterol 2015;39:683-91. [PMID: 25956490 DOI: 10.1016/j.clinre.2015.02.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
116 Chen Y, Ye P, Li Y, Ma S, Zhao J, Zeng Q. Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic, totally occluded, portal vein thrombosis with symptomatic portal hypertension: procedure technique, safety, and clinical applications. Eur Radiol. 2015;25:3431-3437. [PMID: 25903717 DOI: 10.1007/s00330-015-3777-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
117 Luo X, Wang Z, Tsauo J, Zhou B, Zhang H, Li X. Advanced Cirrhosis Combined with Portal Vein Thrombosis: A Randomized Trial of TIPS vs Endoscopic Band Ligation Plus Propranolol for the Prevention of Recurrent Esophageal Variceal Bleeding. Radiology. 2015;276:286-293. [PMID: 25759969 DOI: 10.1148/radiol.15141252] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 8.1] [Reference Citation Analysis]
118 Intagliata NM, Henry ZH, Northup PG. Portal Vein Thrombosis in Patients with Cirrhosis—Etiology, Diagnosis, and Management. Curr Hepatology Rep 2015;14:1-8. [DOI: 10.1007/s11901-015-0249-7] [Reference Citation Analysis]
119 Li X, Liu Y, Zhang C. Correlation Between NAT2 Gene Polymorphism and Cirrhotic Portal Hypertension in the Chinese Population. Genetic Testing and Molecular Biomarkers 2015;19:138-43. [DOI: 10.1089/gtmb.2014.0283] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
120 Chawla YK, Bodh V. Portal vein thrombosis. J Clin Exp Hepatol 2015;5:22-40. [PMID: 25941431 DOI: 10.1016/j.jceh.2014.12.008] [Cited by in Crossref: 97] [Cited by in F6Publishing: 104] [Article Influence: 12.1] [Reference Citation Analysis]
121 Zhou J, Yang JH. Progress in treatment of nontumoral portal vein thrombosis in liver cirrhosis. Shijie Huaren Xiaohua Zazhi 2015; 23(5): 735-740 [DOI: 10.11569/wcjd.v23.i5.735] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
122 Basit SA, Stone CD, Gish R. Portal vein thrombosis. Clin Liver Dis 2015;19:199-221. [PMID: 25454305 DOI: 10.1016/j.cld.2014.09.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
123 Valla D. Portal Vein Thrombosis. Complications of Cirrhosis 2015. [DOI: 10.1007/978-3-319-13614-1_20] [Reference Citation Analysis]
124 Cai J, Guo W, He C, Han G. Shunt dysfunction: is it suitable as the primary end point in transjugular intrahepatic portosystemic shunt trials? J Hepatol 2015;62:245-7. [PMID: 25245892 DOI: 10.1016/j.jhep.2014.08.053] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
125 Raja K, Jacob M, Asthana S. Portal vein thrombosis in cirrhosis. J Clin Exp Hepatol 2014;4:320-31. [PMID: 25755579 DOI: 10.1016/j.jceh.2013.12.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
126 Garcia-pagán JC, Abraldes JG, Bosch J. Transjugular Intrahepatic Portosystemic Shunt. Urgent Interventional Therapies 2014. [DOI: 10.1002/9781118504499.ch45] [Reference Citation Analysis]
127 Qi X, Guo W, He C, Zhang W, Wu F, Yin Z, Bai M, Niu J, Yang Z, Fan D, Han G. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: techniques, indications and results on 51 Chinese patients from a single centre. Liver Int 2014;34:1164-75. [PMID: 24256572 DOI: 10.1111/liv.12355] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 6.8] [Reference Citation Analysis]
128 Nery F, Valla D. Splanchnic and Extrasplanchnic Thrombosis in Cirrhosis: Prophylaxis vs Treatment. Curr Hepatology Rep 2014;13:224-234. [DOI: 10.1007/s11901-014-0233-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
129 Qi X, Han G, Fan D. Management of portal vein thrombosis in liver cirrhosis. Nat Rev Gastroenterol Hepatol 2014;11:435-46. [PMID: 24686266 DOI: 10.1038/nrgastro.2014.36] [Cited by in Crossref: 99] [Cited by in F6Publishing: 107] [Article Influence: 11.0] [Reference Citation Analysis]
130 Boyer TD, Habib S. Portal vein thrombosis in patients with cirrhosis. Clin Liver Dis (Hoboken) 2014;3:111-3. [PMID: 30992901 DOI: 10.1002/cld.331] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
131 Liu L, Zhao Y, Qi X, Cai G, He C, Guo W, Yin Z, Chen H, Chen X, Fan D, Han G. Transjugular intrahepatic portosystemic shunt for symptomatic portal hypertension in hepatocellular carcinoma with portal vein tumor thrombosis. Hepatol Res 2014;44:621-30. [PMID: 23679937 DOI: 10.1111/hepr.12162] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
132 Hibi T, Nishida S, Levi DM, Selvaggi G, Tekin A, Fan J, Ruiz P, Tzakis AG. When and why portal vein thrombosis matters in liver transplantation: A critical audit of 174 cases. Ann Surg. 2014;259:760-766. [PMID: 24299686 DOI: 10.1097/sla.0000000000000252] [Cited by in Crossref: 110] [Cited by in F6Publishing: 89] [Article Influence: 12.2] [Reference Citation Analysis]
133 Luo X, Nie L, Zhou B, Yao D, Ma H, Jiang M, Zhang H, Li X. Transjugular intrahepatic portosystemic shunt for the treatment of portal hypertension in noncirrhotic patients with portal cavernoma. Gastroenterol Res Pract 2014;2014:659726. [PMID: 24868203 DOI: 10.1155/2014/659726] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
134 Zhao JB, Feng C, Zhu QH, He XF, Li YH, Chen Y. Transjugular intrahepatic portosystemic shunt with covered stents for hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol 2014; 20(6): 1602-1607 [PMID: 24587637 DOI: 10.3748/wjg.v20.i6.1602] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
135 Ponziani FR, Zocco MA, Senzolo M, Pompili M, Gasbarrini A, Avolio AW. Portal vein thrombosis and liver transplantation: Implications for waiting list period, surgical approach, early and late follow-up. Transplant Rev (Orlando). 2014;28:92-101. [PMID: 24582320 DOI: 10.1016/j.trre.2014.01.003] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 5.7] [Reference Citation Analysis]
136 Bai M, He CY, Qi XS, Yin ZX, Wang JH, Guo WG, Niu J, Xia JL, Zhang ZL, Larson AC, Wu KC, Fan DM, Han GH. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt. World J Gastroenterol 2014; 20(3): 774-785 [PMID: 24574750 DOI: 10.3748/wjg.v20.i3.774] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
137 Borghei P, Kim SK, Zuckerman DA. Balloon occlusion retrograde transvenous obliteration of gastric varices in two non-cirrhotic patients with portal vein thrombosis. Korean J Radiol 2014;15:108-13. [PMID: 24497799 DOI: 10.3348/kjr.2014.15.1.108] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
138 Zhang WG, Li Z, Ding PX, Ren JZ, Ma J, Zhou PL, Wang ZG, Han XW. Endovascular treatment of an unusual primary arterioportal fistula complicated by cavernous transformation of the portal vein caused by portal thrombosis. Ann Vasc Surg 2014; 28: 491.e5-491. e8. [PMID: 24368181 DOI: 10.1016/j.avsg.2012.10.032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
139 Qi XS, Bai M, He CY, Yin ZX, Guo WG, Niu J, Wu FF, Han GH. Prognostic factors in non-malignant and non-cirrhotic patients with portal cavernoma: an 8-year retrospective single-center study. World J Gastroenterol 2013;19:7447-54. [PMID: 24259977 DOI: 10.3748/wjg.v19.i42.7447] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
140 Chen H, Bai M, Qi X, Liu L, He C, Yin Z, Fan D, Han G. Child-Na score: a predictive model for survival in cirrhotic patients with symptomatic portal hypertension treated with TIPS. PLoS One 2013;8:e79637. [PMID: 24244533 DOI: 10.1371/journal.pone.0079637] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
141 Zhu K, Meng X, Zhou B, Qian J, Huang W, Deng M, Shan H. Percutaneous transsplenic portal vein catheterization: technical procedures, safety, and clinical applications. J Vasc Interv Radiol. 2013;24:518-527. [PMID: 23522157 DOI: 10.1016/j.jvir.2012.12.028] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 4.5] [Reference Citation Analysis]
142 Qi X, Chen H, Han G. Effect of antithrombin, protein C and protein S on portal vein thrombosis in liver cirrhosis: a meta-analysis. Am J Med Sci 2013;346:38-44. [PMID: 23187296 DOI: 10.1097/MAJ.0b013e31826485fc] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 3.3] [Reference Citation Analysis]
143 Gaba RC, Parvinian A. Transjugular intrahepatic portosystemic shunt for maintenance of portal venous patency in liver transplant candidates. J Clin Imaging Sci 2013;3:28. [PMID: 24083066 DOI: 10.4103/2156-7514.115761] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
144 Qi X, He C, Yin Z, Wang Z, Zhang H, Yao L, Wang J, Xia J, Cai H, Yang Z, Bai M, Guo W, Niu J, Wu K, Fan D, Han G; PVT-TIPS Study Group. Transjugular intrahepatic portosystemic shunt for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: study protocol for a randomised controlled trial. BMJ Open 2013;3:e003370. [PMID: 23847271 DOI: 10.1136/bmjopen-2013-003370] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
145 D'Avola D, Bilbao JI, Zozaya G, Pardo F, Rotellar F, Iñarrairaegui M, Quiroga J, Sangro B, Herrero JI. Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation. Transplant Proc 2012;44:2603-5. [PMID: 23146469 DOI: 10.1016/j.transproceed.2012.09.050] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
146 Zhang DL, Hao JY, Yang N. Value of D-dimer and protein S for diagnosis of portal vein thrombosis in patients with liver cirrhosis. J Int Med Res. 2013;41:664-672. [PMID: 23637275 DOI: 10.1177/0300060513483413] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
147 Peck-Radosavljevic M, Angermayr B, Datz C, Ferlitsch A, Ferlitsch M, Fuhrmann V, Häfner M, Kramer L, Maieron A, Payer B. Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II). Wien Klin Wochenschr. 2013;125:200-219. [PMID: 23579878 DOI: 10.1007/s00508-013-0337-z] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
148 Liang YP, Tang YM, Yang JH, You LY. Transjugular intrahepatic portosystemic shunt dysfunction. Shijie Huaren Xiaohua Zazhi 2013; 21(4): 336-340 [DOI: 10.11569/wcjd.v21.i4.336] [Reference Citation Analysis]
149 Otal P, Bureau C, Lagarde S, Mokrane T, Vinel J, Rousseau H. TIPS. Thérapeutiques endovasculaires des pathologies veineuses 2013. [DOI: 10.1007/978-2-8178-0291-6_25] [Reference Citation Analysis]
150 Qi X, Han G, He C, Yin Z, Zhang H, Wang J, Xia J, Cai H, Yang Z, Bai M, Wu K, Fan D. Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesis. Med Sci Monit 2012;18:HY37-41. [PMID: 22847208 DOI: 10.12659/msm.883252] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
151 Chen H, Qi X, He C, Yin Z, Fan D, Han G. Coagulation imbalance may not contribute to the development of portal vein thrombosis in patients with cirrhosis. Thromb Res. 2013;131:173-177. [PMID: 23157737 DOI: 10.1016/j.thromres.2012.11.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
152 Seijo S, García-criado Á, Darnell A, García-pagán JC. Diagnóstico y tratamiento de la trombosis portal en la cirrosis hepática. Gastroenterología y Hepatología 2012;35:660-6. [DOI: 10.1016/j.gastrohep.2012.02.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
153 Qi X, Han G, Yin Z, He C, Guo W, Niu J, Wu K, Fan D. Cavernous vessels around a patent portal trunk in the liver hilum. Abdom Imaging 2012;37:422-30. [PMID: 21789553 DOI: 10.1007/s00261-011-9779-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
154 Pomier-Layrargues G, Bouchard L, Lafortune M, Bissonnette J, Guérette D, Perreault P. The transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension: current status. Int J Hepatol. 2012;2012:167868. [DOI: 10.1155/2012/167868] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
155 Delgado MG, Seijo S, Yepes I, Achécar L, Catalina MV, García-Criado A, Abraldes JG, de la Peña J, Bañares R, Albillos A, Bosch J, García-Pagán JC. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. Clin Gastroenterol Hepatol 2012;10:776-83. [PMID: 22289875 DOI: 10.1016/j.cgh.2012.01.012] [Cited by in Crossref: 266] [Cited by in F6Publishing: 257] [Article Influence: 24.2] [Reference Citation Analysis]
156 Francoz C, Valla D, Durand F. Portal vein thrombosis, cirrhosis, and liver transplantation. J Hepatol 2012;57:203-12. [PMID: 22446690 DOI: 10.1016/j.jhep.2011.12.034] [Cited by in Crossref: 159] [Cited by in F6Publishing: 163] [Article Influence: 14.5] [Reference Citation Analysis]
157 Maruyama H, Takahashi M, Shimada T, Yokosuka O. Emergency anticoagulation treatment for cirrhosis patients with portal vein thrombosis and acute variceal bleeding. Scand J Gastroenterol 2012;47:686-91. [PMID: 22472055 DOI: 10.3109/00365521.2012.674972] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
158 Qi X, Zhang C, Han G, Zhang W, He C, Yin Z, Liu Z, Bai W, Li R, Bai M, Yang Z, Wu K, Fan D. Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis: a prospective study. J Gastroenterol Hepatol 2012;27:1036-43. [PMID: 22142461 DOI: 10.1111/j.1440-1746.2011.07040.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 5.5] [Reference Citation Analysis]
159 Hong R, Dhanani RS, Louie JD, Sze DY. Intravascular ultrasound-guided mesocaval shunt creation in patients with portal or mesenteric venous occlusion. J Vasc Interv Radiol. 2012;23:136-141. [PMID: 22221479 DOI: 10.1016/j.jvir.2011.09.029] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
160 Qi X, Han G, Yin Z, He C, Wang J, Guo W, Niu J, Zhang W, Bai M, Fan D. Transjugular intrahepatic portosystemic shunt for portal cavernoma with symptomatic portal hypertension in non-cirrhotic patients. Dig Dis Sci 2012;57:1072-82. [PMID: 22147244 DOI: 10.1007/s10620-011-1975-5] [Cited by in Crossref: 65] [Cited by in F6Publishing: 72] [Article Influence: 5.9] [Reference Citation Analysis]
161 Gerbes AL, Gülberg V. Aszites, Pfortaderthrombose und hepatische Enzephalopathie bei Leberzirrhose: Aktuelle Therapieempfehlungen. Viszeralmedizin 2012;28:297-303. [DOI: 10.1159/000343293] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
162 Plessier A, Rautou PE, Valla DC. Management of hepatic vascular diseases. J Hepatol 2012;56 Suppl 1:S25-38. [PMID: 22300463 DOI: 10.1016/S0168-8278(12)60004-X] [Cited by in Crossref: 149] [Cited by in F6Publishing: 148] [Article Influence: 13.5] [Reference Citation Analysis]
163 Qi X, Han G. Transjugular intrahepatic portosystemic shunt in the treatment of portal vein thrombosis: a critical review of literature. Hepatol Int 2012;6:576-90. [PMID: 26201472 DOI: 10.1007/s12072-011-9324-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 3.1] [Reference Citation Analysis]
164 Senzolo M, Burra P, Patch D, Burroughs AK. Tips for portal vein thrombosis (pvt) in cirrhosis: not only unblocking a pipe. J Hepatol 2011;55:945-6; author reply 947-8. [PMID: 21419182 DOI: 10.1016/j.jhep.2011.02.027] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
165 Tripodi A, Anstee QM, Sogaard KK, Primignani M, Valla DC. Hypercoagulability in cirrhosis: causes and consequences1: Hypercoagulability in cirrhosis. Journal of Thrombosis and Haemostasis 2011;9:1713-23. [DOI: 10.1111/j.1538-7836.2011.04429.x] [Cited by in Crossref: 185] [Cited by in F6Publishing: 198] [Article Influence: 15.4] [Reference Citation Analysis]
166 Bai M, Qi X, Yang Z, Yin Z, Nie Y, Yuan S, Wu K, Han G, Fan D. Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review. J Gastroenterol Hepatol 2011;26:943-51. [PMID: 21251067 DOI: 10.1111/j.1440-1746.2011.06663.x] [Cited by in Crossref: 115] [Cited by in F6Publishing: 115] [Article Influence: 9.6] [Reference Citation Analysis]
167 Qi X, Han G, Bai M, Fan D. Stage of portal vein thrombosis. J Hepatol 2011;54:1080-2; author reply 1082-3. [PMID: 21145872 DOI: 10.1016/j.jhep.2010.10.034] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
168 Qi X, Han G, Yin Z, He C, Bai M, Yang Z, Guo W, Niu J, Wu K, Fan D. A large portal vein: a rare finding of recent portal vein thrombosis. Case Rep Gastroenterol 2011;5:33-9. [PMID: 21326856 DOI: 10.1159/000323386] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
169 Qi X, Bai M, Yang Z, Yuan S, Zhang C, Han G, Fan D. Occlusive portal vein thrombosis as a new marker of decompensated cirrhosis. Med Hypotheses 2011;76:522-6. [PMID: 21216538 DOI: 10.1016/j.mehy.2010.12.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
170 Harnois D. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. Yearbook of Gastroenterology 2011;2011:256-257. [DOI: 10.1016/j.ygas.2011.07.032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]